Connect with us

INDUSTRIAL HEMP

Aurora Cannabis Inc (OTCMKTS:ACBFF) Closes Larssen And H2 Biopharma Acquisitions

Published

on

Aurora Cannabis Inc (OTCMKTS:ACBFF) reported that further to its PR of November 23, 2017, the firm has completed the acquisition deals of Larssen Ltd and H2 Biopharma. Larssen has established the industry standard in advanced, automated, environmentally regulated greenhouses for more than 30 years. It has consulted on the engineering, construction and design oversight of several of the world’s state-of-the-art greenhouse grow facilities, having been engaged with more than 1,000 projects around the world. As of now, Larssen is involved in fifteen cannabis projects.

The highlights

H2 is currently working on an advanced, purpose-built cannabis production facility, which, upon completion, is estimated to produce around 4,500 kilograms of premium quality cannabis per annum, with considerable expansion potential on 46 acres of land, which H2 has the privilege to buy for $136,000. Aurora Larssen Projects Ltd., which was recently established as Aurora’s greenhouse design and consulting unit, will play a vital role in the completion of the latest facility to EU GMP standards.

Terry Booth, the CEO of Aurora, expressed that there are two vital acquisitions for company that clearly demonstrate how their expanding constellation of trusted subsidiaries and partners boost shareholder value creation via strategic synergies. Larssen’s pedigree in advancing the world’s most efficient and technologically advanced greenhouses will be used for the completion of their new Lachute Facility. The establishment of this latest facility will enhance their capacity to serve the export and domestic markets, and signals their key commitment to businesses in Quebec.

Projecting for $6 million in FY2018 revenues, the Larssen deal will be immediately accretive. Closure of the H2 facility is projected for early 2018 with production, and hence additional revenues, projected shortly thereafter. In view of the H2 deal, Aurora has issued around 4.789 million common shares to the H2 vendors for $5.22 per share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement